Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chemotherapy-induced Thrombocytopenia × oprelvekin × Classical hematology × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Colorectal Neoplasms 1 Chemotherapy-induced Thrombocytopenia 1 CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

oprelvekin 1 hetrombopag 1 eltrombopag 1 avatrombopag 1 Interleukin-11 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05688306 2023-01-18

To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment

Liaoning Cancer Hospital & Institute

Classical hematology

Chemotherapy-induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡